PRTA FY 2022 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$54M-73.1% YoY

Gross Profit

$54M100.0% margin

Operating Income

-$132M-244.1% margin

Net Income

-$117M-217.0% margin

EPS (Diluted)

$-2.47

Cash Flow

Operating Cash Flow

-$109M

Free Cash Flow

-$109M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$758M

Total Liabilities

$136M

Stockholders' Equity

$622M

Cash & Equivalents

$710M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$201M	-73.1%
Gross Profit	$54M	$201M	-73.1%
Operating Income	-$132M	$72M	-282.8%
Net Income	-$117M	$67M	-274.6%